Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-27 Sale | 2021-08-27 4:55 pm | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 33,779 | $60.12 | $2,030,864 | 263,340 (Direct) | View |
| 2021-08-17 Sale | 2021-08-19 4:30 pm | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 54,000 | $50.37 | $2,720,182 | 297,119 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-08-27 Exercise | 2021-08-27 4:55 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 33,779 | $0 | 263,340 (Direct) | View |
| 2021-08-27 Exercise | 2021-08-27 4:55 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 33,779 | $20 | 263,340 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 4:30 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 54,000 | $0 | 297,119 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 54,000 | $20 | 297,119 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:52 pm | N/A 2031-02-28 | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:28 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 351,119 | $0 | 351,119 (Direct) | View |